Commitment to Action

Genetic Care Interchange

Commitment by

Life Technologies

In partnership with Lybba, a non-profit open-source healthcare platform, Life Technologies commits to improving cancer care by creating the Genetic Care Interchange, an exchange of genetic and medical knowledge that confronts the genetic complexity of cancer, turning it into a source of beneficial insights. Several networked institutions will genetically profile 100,000 patients to create a single medical repository. The network will provide broad access to the collective experience of patients with genetic similarities to find targeted treatment options, and enable researchers to identify new genetically defined targets for drug development, completing the circle of personalized cancer care.

Share

Tabs

Overview
Summary

Commitment

Genetic Care Interchange

Launched

2011

Est. Duration

4 Years

Estimated Total Value

$5,500,000

Region

Oceania, Europe, Northern America

Countries

Australia, GERMANY, UNITED KINGDOM, United States

Commitment by

Life Technologies

Partner(s) of the Commitment Maker(s)

Oxford University, Fox Chase Cancer Center, Lybba